Evidence map›Paper›PMID 32426510›Full record

ArticleScience advances2020

Altered d-glucose in brain parenchyma and cerebrospinal fluid of early Alzheimer's disease detected by dynamic glucose-enhanced MRI.

Jianpan Huang, Peter C M van Zijl, Xiongqi Han, Celia M Dong, Gerald W Y Cheng, Kai-Hei Tse, Linda Knutsson, Lin Chen, Joseph H C Lai, Ed X Wu and 2 more

Open access · goldAbstract read
In one paragraph

Article in Science advances, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 55 papers.

0numbers the graph read from it
0cells of the map it votes in
55citing papers in PubMed
6.2field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

55 citing papers in PubMed, 98 citations in OpenAlex.

  1. Catalyzing MRI: An Enzymatic Strategy forChemical & biomedical imaging · 2026
    Article
  2. Dynamic glucose-enhanced MRI in brain tumors.Magma (New York, N.Y.) · 2026
    Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 4 countries.

Jianpan HuangDepartment of Biomedical Engineering, City University of Hong Kong, Hong Kong, China.ORCID 0000-0002-4453-8764
Peter C M van ZijlRussell H. Morgan Department of Radiology and Radiological Science, The Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Xiongqi HanDepartment of Biomedical Engineering, City University of Hong Kong, Hong Kong, China.ORCID 0000-0003-3557-0268
Celia M DongDepartment of Electrical and Electronic Engineering, The University of Hong Kong, Hong Kong, China.
Gerald W Y ChengDepartment of Health Technology and Informatics, The Hong Kong Polytechnic University, Hong Kong, China.ORCID 0000-0002-1199-3592
Kai-Hei TseDepartment of Health Technology and Informatics, The Hong Kong Polytechnic University, Hong Kong, China.ORCID 0000-0001-7287-3984
Linda KnutssonRussell H. Morgan Department of Radiology and Radiological Science, The Johns Hopkins University School of Medicine, Baltimore, MD, USA.ORCID 0000-0002-4263-113X
Lin ChenRussell H. Morgan Department of Radiology and Radiological Science, The Johns Hopkins University School of Medicine, Baltimore, MD, USA.ORCID 0000-0003-0108-4309
Joseph H C LaiDepartment of Biomedical Engineering, City University of Hong Kong, Hong Kong, China.ORCID 0000-0002-5376-8350
Ed X WuDepartment of Electrical and Electronic Engineering, The University of Hong Kong, Hong Kong, China.ORCID 0000-0001-5581-1546
Jiadi XuRussell H. Morgan Department of Radiology and Radiological Science, The Johns Hopkins University School of Medicine, Baltimore, MD, USA.ORCID 0000-0001-9698-5622
Kannie W Y ChanDepartment of Biomedical Engineering, City University of Hong Kong, Hong Kong, China.ORCID 0000-0002-7315-1550
City University of Hong Kong · HKKennedy Krieger Institute · USHong Kong Polytechnic University · HKJohns Hopkins University · USUniversity of Hong Kong · HK

Funding

Development and Translation of D-glucose as a Diagnostic Agent for MRI of CancerR01EB019934 · NIBIB · HUGO W. MOSER RES INST KENNEDY KRIEGER · PI VAN ZIJL, PETER CM · 2015 to 2019
$5.7M
NIBIB NIH HHS R01 EB019934
6 · The paper itself

Abstract

Altered cerebral glucose uptake is one of the hallmarks of Alzheimer's disease (AD). A dynamic glucose-enhanced (DGE) magnetic resonance imaging (MRI) approach was developed to simultaneously monitor d-glucose uptake and clearance in both brain parenchyma and cerebrospinal fluid (CSF). We observed substantially higher uptake in parenchyma of young (6 months) transgenic AD mice compared to age-matched wild-type (WT) mice. Notably lower uptakes were observed in parenchyma and CSF of old (16 months) AD mice. Both young and old AD mice had an obviously slower CSF clearance than age-matched WT mice. This resembles recent reports of the hampered CSF clearance that leads to protein accumulation in the brain. These findings suggest that DGE MRI can identify altered glucose uptake and clearance in young AD mice upon the emergence of amyloid plaques. DGE MRI of brain parenchyma and CSF has potential for early AD stratification, especially at 3T clinical field strength MRI.

Indexed as

Alzheimer DiseaseAmyloid beta-PeptidesAnimalsBrainGlucoseMagnetic Resonance ImagingMiceMice, TransgenicPlaque, AmyloidAmyloid beta-PeptidesGlucose

Identifiers

PMID32426510
PMCPMC7220384
OpenAlexW3024439707

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.